Carolina Reduzzi

Company: Weill Cornell Medicine,

Job title: Associate Professor & Director of Liquid Biopsies

Seminars:

Leveraging Multi-Analyte Liquid Biopsy to Reveal Novel Insights into Treatment Response & MRD Assessment 11:30 am

Demonstrating the utility of CTCs for biomarker-driven treatment selection and monitoring  How can we leverage more sensitive assays to enhance CTC applications in the early setting? The cellular residual disease (CRD) concept What can a multi-analyte approach offer in the context of MRD detection? Combining MRD and CRD Novel AnalyteRead more

day: Conference Day 2

Panel Discussion:Driving Consensus on Analytical Validation Requirements to Expedite Liquid Biopsy Integration in Oncology 12:00 pm

What regulatory and industry collaborations are needed to drive consensus on analytical validation requirements for liquid biopsy in oncology? How can we ensure that liquid biopsy assays are validated for their intended use in clinical trials to avoid discrepancies in biomarker interpretation? Given the lack of standardization in LBx, what steps should be taken to…Read more

day: Conference Day 2